Author/Authors :
Harris, Alex H. S. Center for Innovation to Implementation - Health Services Research and Development - VA Palo Alto Health Care System, Menlo Park, CA USA , Bowe, Thomas Center for Innovation to Implementation - Health Services Research and Development - VA Palo Alto Health Care System, Menlo Park, CA USA , Hagedorn, Hildi Center for Innovation to Implementation - Health Services Research and Development - VA Palo Alto Health Care System, Menlo Park, CA USA , Nevedal, Andrea Center for Innovation to Implementation - Health Services Research and Development - VA Palo Alto Health Care System, Menlo Park, CA USA , Finlay, Andrea K. Center for Innovation to Implementation - Health Services Research and Development - VA Palo Alto Health Care System, Menlo Park, CA USA , Gidwani, Risha Center for Innovation to Implementation - Health Services Research and Development - VA Palo Alto Health Care System, Menlo Park, CA USA , Rosen, Craig Center for Innovation to Implementation - Health Services Research and Development - VA Palo Alto Health Care System, Menlo Park, CA USA , Kay, Chad Center for Innovation to Implementation - Health Services Research and Development - VA Palo Alto Health Care System, Menlo Park, CA USA , Christopher, Melissa Center for Innovation to Implementation - Health Services Research and Development - VA Palo Alto Health Care System, Menlo Park, CA USA
Abstract :
Background: Active consideration of effective medications to treat alcohol use disorder (AUD) is a consensus stand-
ard of care, yet knowledge and use of these medications are very low across diverse settings. This study evaluated the
overall effectiveness a multifaceted academic detailing program to address this persistent quality problem in the US
Veterans Health Administration (VHA), as well as the context and process factors that explained variation in effective-
ness across sites.
Methods: An interrupted time series design, analyzed with mixed-effects segmented logistic regression, was used
to evaluate changes in level and rate of change in the monthly percent of patients with a clinically documented AUD
who received naltrexone, acamprosate, disulfiram, or topiramate. Using data from a 20 month post-implementation
period, intervention sites (n = 37) were compared to their own 16 month pre-implementation performance and
separately to the rest of VHA.
Results: From immediately pre-intervention to the end of the observation period, the percent of patients in the
intervention sites with AUD who received medication increased over 3.4 % in absolute terms and 68 % in relative
terms (i.e., 4.9–8.3 %). This change was significant compared to the pre-implementation period in the intervention
sites and secular trends in control sites. Sites with lower pre-implementation adoption, more person hours of detail-
ing, but fewer people detailed, had larger immediate increases in medication receipt after implementation. The aver-
age number of detailing encounters per person was associated with steeper increases in slope over time.
Conclusions: This study found empirical support for a multifaceted quality improvement strategy aimed at increas-
ing access to and utilization of pharmacotherapy for AUD. Future studies should focus on determining how to
enhance the programs effects, especially in non-responsive locations.
Keywords :
Pharmacotherapy , Medication assisted treatment , Alcohol use disorder , Quality improvement , Implementation , Guideline adherence , Practice guidelines